Anavex Life Sciences (AVXL) Total Debt (2009 - 2016)
Anavex Life Sciences (AVXL) recorded Total Debt of $92,516 in fiscal Q3 2015 (quarter ended Jun 30, 2015), down 53.9% from $200,835 a year earlier but up 2.3% from the prior quarter.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Total Debt (2009 - 2016) Analysis & Trends
At the end of FY2014 (ended Sep 30, 2014), Anavex Life Sciences reported Total Debt of $192,065, down 8.9% from FY2013.
- Annual Total Debt has declined for three straight fiscal years, with a three-year compound annual growth rate of -39.5% (FY2011 to FY2014).
- Across earlier fiscal years, Total Debt came in at $210,863 in FY2013 (-29.5%), $299,000 in FY2012 (-65.5%) and $867,919 in FY2011.
- Quarterly Total Debt has ranged from $49,000 in fiscal Q3 2012 to $1.2 million in fiscal Q2 2012 over the past five years.
- On a year-over-year basis, Total Debt has declined for eight consecutive quarters, with an average decline of 51.4% over the last eight quarters.
- Over the past five years, the year-over-year decline in Total Debt ranged from 8.9% (fiscal Q4 2014) to 74.6% (fiscal Q2 2014).
- Per Business Quant, the preceding three fiscal quarters came in at $90,412 (Q2 2015), $98,312 (Q1 2015) and $192,065 (Q4 2014).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 49.50 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 44.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 80.90 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 53.78 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -6.68 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 54.01 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 26.23 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 62.67 Bn |
| 10 | Anavex Life Sciences | 104.75 Mn | -375.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | 87,887.00 |
| Mar 31, 2016 | 88,145.00 |
| Dec 31, 2015 | 82,410.00 |
| Sep 30, 2015 | 85,238.00 |
| Jun 30, 2015 | 150,478.00 |
| Mar 31, 2015 | 90,412.00 |
| Dec 31, 2014 | 98,312.00 |
| Sep 30, 2014 | 455,792.00 |
| Jun 30, 2014 | 200,835.00 |
| Mar 31, 2014 | 193,720.00 |
| Dec 31, 2013 | 200,364.00 |
| Sep 30, 2013 | 210,863.00 |
| Jun 30, 2013 | 757,600.00 |
| Mar 31, 2013 | 761,292.00 |
| Dec 31, 2012 | 599,111.00 |
| Sep 30, 2012 | 299,576.00 |
| Jun 30, 2012 | 50,040.00 |
| Mar 31, 2012 | 1.20 Mn |
| Dec 31, 2011 | 1.16 Mn |
| Sep 30, 2011 | 870,353.00 |
API Access
Anavex Life Sciences Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();